FGP
CLOV icon

Freestone Grove Partners’s Clover Health Investments CLOV Stock Holding History

Freestone Grove Partners’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-127,584
Closed -$402K – 617
2024
Q4 		$402K Buy
+127,584
New +$456K ﹤0.01% 413

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Freestone Grove Partners's CLOV Position: Q1 2025 in Review

Freestone Grove Partners sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 127,584 shares — an estimated $402K sold.

Freestone Grove Partners first reported a position in CLOV in Q4 2024 and held it in 1 quarter. The position peaked at $402K in Q4 2024. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

  • Freestone Grove Partners reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 127,584 Clover Health Investments shares in Q1 2025, an estimated $402K.
  • Freestone Grove Partners first reported a position in Clover Health Investments in Q4 2024 and held it in 1 quarter.
  • Freestone Grove Partners's Clover Health Investments position peaked at $402K in Q4 2024.
  • 202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Freestone Grove Partners's 13F filing for Q1 2025, filed 15 May 2025.